Targeting the tumor stroma in hepatocellular carcinoma

doi:10.4254/wjh.v7.i2.165

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14297)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

780

WORD

324

HTML

7848

Figures (1-2)

327

Tables (1-1)

270

Sum=9549

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

682

Download

1140

Sum=1822

Publishing Process of This Article

Item

Count

Browse

1379

Download

1547

Sum=2926

Feb 27, 2015 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (58)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Feb 27, 2015; 7(2): 165-176
Published online Feb 27, 2015. doi: 10.4254/wjh.v7.i2.165

Full Size Figure Download Figure

Figure 2 Schematic overview of (simplified) signaling pathways involved in the tumor-stroma interaction, and therapeutic targets that are currently tested in hepatocellular carcinoma. IL: Interleukin; TGF: Transforming growth factor; mTOR: Mammalian target of rapamycin.

Citation: Heindryckx F, Gerwins P. Targeting the tumor stroma in hepatocellular carcinoma. World J Hepatol 2015; 7(2): 165-176
URL: https://www.wjgnet.com/1948-5182/full/v7/i2/165.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i2.165